Janney Montgomery Scott
TNDM icon

Janney Montgomery Scott’s Tandem Diabetes Care TNDM Stock Holding History

Janney Montgomery Scott’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,450
Closed -$737K – 2827
2025
Q1 		$737K Buy
38,450
+8,210
+27% +$240K ﹤0.01% 1738
2024
Q4 		$1.09M Buy
30,240
+4,412
+17% +$149K ﹤0.01% 1494
2024
Q3 		$1.09M Sell
25,828
-5,210
-17% -$221K ﹤0.01% 1457
2024
Q2 		$1.25M Sell
31,038
-3,468
-10% -$145K ﹤0.01% 1327
2024
Q1 		$1.22M Buy
34,506
+1,493
+5% +$40K ﹤0.01% 1420
2023
Q4 		$977K Buy
33,013
+11,789
+56% +$245K ﹤0.01% 1461
2023
Q3 		$441K Buy
21,224
+2,051
+11% +$56.3K ﹤0.01% 1860
2023
Q2 		$471K Buy
19,173
+4,526
+31% +$146K ﹤0.01% 1905
2023
Q1 		$595K Buy
14,647
+1,419
+11% +$58.8K ﹤0.01% 1615
2022
Q4 		$595K Buy
13,228
+2,688
+26% +$122K ﹤0.01% 1666
2022
Q3 		$504K Buy
10,540
+3,748
+55% +$205K ﹤0.01% 1696
2022
Q2 		$410K Buy
6,792
+1,127
+20% +$92.5K ﹤0.01% 1718
2022
Q1 		$659K Sell
5,665
-100
-2% -$11.7K ﹤0.01% 1475
2021
Q4 		$868K Buy
5,765
+1,066
+23% +$144K ﹤0.01% 1414
2021
Q3 		$561K Sell
4,699
-396
-8% -$43.6K ﹤0.01% 1583
2021
Q2 		$496K Buy
5,095
+795
+18% +$70.9K ﹤0.01% 1642
2021
Q1 		$379K Buy
4,300
+375
+10% +$34.9K ﹤0.01% 1719
2020
Q4 		$376K Sell
3,925
-125
-3% -$12.9K ﹤0.01% 1740
2020
Q3 		$460K Buy
4,050
+400
+11% +$42K ﹤0.01% 1464
2020
Q2 		$361K Sell
3,650
-440
-11% -$35.1K ﹤0.01% 1524
2020
Q1 		$263K Sell
4,090
-775
-16% -$54.3K ﹤0.01% 1551
2019
Q4 		$290K Sell
4,865
-875
-15% -$54K ﹤0.01% 1728
2019
Q3 		$339K Sell
5,740
-410
-7% -$26.2K ﹤0.01% 1617
2019
Q2 		$397K Sell
6,150
-1,650
-21% -$106K ﹤0.01% 1558
2019
Q1 		$495K Sell
7,800
-11,775
-60% -$619K ﹤0.01% 1402
2018
Q4 		$743K Buy
19,575
+1,760
+10% +$62.1K 0.01% 1081
2018
Q3 		$763K Buy
+17,815
New +$622K 0.01% 1206

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Janney Montgomery Scott's TNDM Position: Q2 2025 in Review

Janney Montgomery Scott sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 38,450 shares — an estimated $737K sold.

Janney Montgomery Scott first reported a position in TNDM in Q3 2018 and held it in 27 quarters. The position peaked at $1.25M in Q2 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Janney Montgomery Scott reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 38,450 Tandem Diabetes Care shares in Q2 2025, an estimated $737K.
  • Janney Montgomery Scott first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 27 quarters.
  • Janney Montgomery Scott's Tandem Diabetes Care position peaked at $1.25M in Q2 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Janney Montgomery Scott's 13F filing for Q2 2025, filed 17 Jul 2025.